|
Use of proteomics for the quality control of intravenous immunoglobulins |
PLPROT |
October 1, 2013 |
September 30, 2017 |
Quality of vaccines and blood products |
proteomics, quality control, immunoglobulins, plasma derivatives |
|
Program PRECISION: The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment |
PRECISION |
January 9, 2016 |
|
Cancer centre |
cancer, NGS, CGP, targeted-therapy |
|
Development, testing, and implementation of the Belgian Patient Reported Experience measure for PAncreatic cancer caRE |
PREPARE |
February 1, 2023 |
|
Cancer centre |
cancer, chronic diseases |
|
A study on intentions, attitudes and competencies regarding health promotion in the Flemish population |
Prevention barometer |
December 15, 2019 |
June 15, 2023 |
Health information |
survey, prevention, health promotion, behaviour determinants, lifestyle, Health behaviour, health status |
|
Development of a prioritisation strategy for hazard characterisation of substances migrating from printed paper and board food contact materials based on their genotoxicity |
PRIMISTRA |
February 17, 2014 |
February 14, 2018 |
Risk and health impact assessment, Organic contaminants and additives |
food contact materials, printing inks, paperboard, genotoxicity, gene mutation, in silico, in vitro, 3R |
|
Fingerprinting of Smoke and Vape Products |
PrintSmoke |
October 1, 2022 |
September 30, 2026 |
Medicines and health products |
e-cigarettes, tobacco products, additives, illegal components |
|
Determination of propylene glycol levels in foodstuffs and exposure assessment for the Belgian population |
PROPYLENE GLYCOL DRINKS |
December 1, 2019 |
January 22, 2021 |
Organic contaminants and additives |
food additives, Propane-1, 2-diol (propylene glycol), E1520, non-alcoholic drinks, exposure assessment |
|
Address and reduce drug use of persons in prison and those recently released through data analysis and intervention programs |
PRS20 |
January 1, 2021 |
June 30, 2023 |
Health information |
licit and illicit drugs, drug use, monitoring drugs, patterns of use |
|
Problematic drug use and infectious diseases in Brussels (Belgium) |
Push |
January 1, 2019 |
December 31, 2019 |
Health information |
licit and illicit drugs, injecting drug use, monitoring drugs, patterns of use, hepatitis C virus (HCV) |
|
An interdisciplinary strategy to identify medical devices as a source of allergic or pyrogenic reactions |
QMED |
January 17, 2022 |
January 17, 2026 |
Medicines and health products, Quality of laboratories , Healthcare-associated infections and antimicrobial resistance, Mycology and aerobiology , Foodborne pathogens, Strategy external positioning |
risk assessment, risk management, chronic diseases, allergy, pyrogens, allergic contact dermatitis, device associated infections, analytical chemistry, in vintro testing |
|
Development of a next-generation dual-target rabies/flavivirus plasmid-launched live-attenuated vaccine |
Rabyd-Vax |
January 1, 2017 |
December 31, 2020 |
Viral diseases, Immune response |
rabies, yellow fever, vaccine, plasmid, vector |
|
Retail drug quality project on heroin in 2023 |
RADAR-heroin-23 |
February 1, 2023 |
June 30, 2023 |
Medicines and health products, Health information |
opioid crisis, fentanyl, retail level, heroin, illicit drugs, purity |
|
Coordination of the Risk Assessment Group |
RAG |
January 1, 2007 |
|
Foodborne pathogens, Viral diseases, Epidemiology of infectious diseases, Avian virology and immunology, Crisis Coordination |
risk analysis, crisis management |
|
Lumpy skin disease in Belgian cattle and potential vectors: risk assessment, diagnosis, control, vaccination, transmission and vector competence studies to prevent the introduction and spread |
RCO LUMPY SKIN |
January 1, 2016 |
December 31, 2018 |
Viral reemerging enzootic and bee diseases, Exotic and vector-borne diseases |
lumpy skin disease, risk assessment, diagnosis, control, vaccination, transmission, vector competence |
|
An online tool to collect New Approach Methodologies (NAMs) in one central database |
RE-Place |
April 18, 2017 |
April 30, 2024 |
Risk and health impact assessment |
3R, replacement, alternative methods, in vitro, in silico, in chemico, new technologies |
|
Exploring the person-centredness of the Investigation to reveal the immune reaction upon COVID-vaccination in the Belgian cancer population: COVID protection and Vaccine safety study |
REAL-V |
January 1, 2022 |
March 31, 2023 |
Cancer centre |
patient-centered-care, life change event, clinical trials |
|
Context-Specific Interventions for Nutrition-Related Non-Communicable Diseases Prevention in East Africa |
RECAP |
April 1, 2020 |
March 31, 2023 |
Health information |
non-communicable diseases, low-middle income countries, food environments, nutrition policy, food marketing |
|
Reference materials as metrological tools for emerging and regulated mycotoxins and for animal experiments |
RefMat |
January 2, 2010 |
|
|
Matrix reference materials, safety, mycotoxins, food, feed, metrology, quality control, interlaboratory comparison, carry-over, mitigation, metabolite profiling, metrofood |
|
Release of nano-objects, their aggregates and agglomerates from protective face masks |
Renaame |
January 1, 2023 |
March 25, 2026 |
Trace elements and nanomaterials |
|
|
Responding to outbreaks through co-creative inclusive equality strategies and collaboration |
RESISTIRÉ |
April 1, 2021 |
September 30, 2023 |
|
COVID-19, gender, social inequalities, Europe |
|
Development and application of differential diagnosis for respiratory viruses to improve surveillance and understanding of acute respiratory infectious disease in Belgium |
Respi |
October 1, 2015 |
December 31, 2019 |
Epidemiology and public health, Viral diseases |
influenza virus, respiratory viruses, severity, co-infection |
|
Assessing spatio-temporal relationships between respiratory health and biodiversity using individual wearable technology |
RespirIT |
December 15, 2015 |
September 15, 2020 |
Mycology and aerobiology , Risk and health impact assessment |
allergy, pollen, mobile health, ecohealth, rhinitis, respiratory health, GPS tracking, citizen science, biodiversity |
|
Risk-based Screening for Cervical Cancer (RISCC) |
RISCC |
January 1, 2020 |
December 21, 2024 |
Cancer centre |
screen programme, risk assessment, numerical analysis, simulation, optimisation, modelling tools, cervical cancer screening, risk stratification, predictive modelling, health-economic modelling, digital applications |
|
Study on the prevalence of antibodies against the coronavirus (SARS-CoV-2) in the Belgian population |
SalivaHIS |
January 1, 2021 |
June 30, 2022 |
Viral diseases, Immune response, Laboratory of medical microbiology (LMM), Health information, Epidemiology of infectious diseases |
|
|
Salmonella biofilm formation in chronic carrier pigs: impact on gut colonization & antibiotic tolerance; functional diagnostics; and potential as target for non-antibiotic therapy |
SalmiPIG |
July 1, 2021 |
June 30, 2025 |
Transversal activities in applied genomics |
biofilm, salmonella, genetic marker, pig, pork, whole genome sequencing, bioinformatics, variant analysis |
|
More rapid and accurate identification of (zoonotic) Salmonella serotypes that are the object of official control in poultry and pork |
SALMSTID |
November 1, 2015 |
August 31, 2018 |
Bacterial diseases, Transversal activities in applied genomics |
salmonella, genetic serotyping, Luminex, Multiplex |
|
Severe Acute Respiratory Infection surveillance by a sentinel network of hospitals |
SARI |
January 1, 2012 |
|
Viral diseases, Epidemiology of infectious diseases |
SARI surveillance, severe acute respiratory infections, sentinel, Influenza |
|
Surveillance of antimicrobial resistance in primary care - focus on uncomplicated uninary tract infections |
SARPRIC-UTI |
January 1, 2023 |
December 31, 2024 |
Healthcare-associated infections and antimicrobial resistance |
surveillance, antimicrobial resistance, AMR, primary health care, general medicine |
|
SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the COVID-19 outbreak between April 2020 and April 2021 |
SARS-CoV-2 HCW |
March 1, 2020 |
July 31, 2021 |
Healthcare-associated infections and antimicrobial resistance |
COVID-19, SARS-CoV-2, seroprevalence, healthcare worker, infection control, public health |
|
Understanding the dynamics and consequences of new psychoactive substances use in a rapidly changing (online) drug market |
SCANNER |
October 1, 2020 |
November 30, 2022 |
Health information |
NPS, new psychoactive substances, illicit drugs, drug use, influence legislation, ringtesting, proficiency testing, helplines and drug checking services, civil society organisations, fentanyl hotspots |
